Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Dalafenil Intermediate
Dalafenil Is A Competitive Raf Inhibitor Of Atp. The Ic50 Of C-Raf And B-Rafv600E Is 5 Nm And 0.6 Nm, Respectively. It Is A Drug For The Treatment Of Cancer Associated With Mutated Braf Gene. As An Inhibitor Of Related Enzyme B-Raf, It Plays A Role In The
No data